About BioAmp Diagnostics
BioAmp Diagnostics is a company based in Berkeley (United States) founded in 2017 by Nicole Tarlton.. BioAmp Diagnostics offers products and services including DETECT Technology. BioAmp Diagnostics operates in a competitive market with competitors including Lodestone Biomedical, Araceli Biosciences, BioImage, HAWK Biosystems and Genosaber, among others.
- Headquarter Berkeley, United States
- Founders Nicole Tarlton
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$243.81 K (USD), Grant
Apr 02, 2024
-
Investors
Illumina
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAmp Diagnostics
BioAmp Diagnostics offers a comprehensive portfolio of products and services, including DETECT Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid chemistry-based system for quick infection detection and antibiotic guidance.
Unlock access to complete
Unlock access to complete
Funding Insights of BioAmp Diagnostics
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $243,806
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Grant - BioAmp Diagnostics | Valuation |
investors |
|
| May, 2021 | Amount | Grant - BioAmp Diagnostics | Valuation |
investors |
|
| May, 2020 | Amount | Grant - BioAmp Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioAmp Diagnostics
BioAmp Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, National Science Foundation and America’s Seed Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Founded Year | Domain | Location | |
|
Startup accelerator program is backed by University of California.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioAmp Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioAmp Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioamp Diagnostics Comparisons
Competitors of BioAmp Diagnostics
BioAmp Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, Araceli Biosciences, BioImage, HAWK Biosystems and Genosaber, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| domain | founded_year | HQ Location |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
|
| domain | founded_year | HQ Location |
Bioassays are developed for biopharmaceutical firms and research organizations.
|
|
| domain | founded_year | HQ Location |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| domain | founded_year | HQ Location |
Diagnostic tools for detecting circulating tumor cells are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioAmp Diagnostics
When was BioAmp Diagnostics founded?
BioAmp Diagnostics was founded in 2017.
Where is BioAmp Diagnostics located?
BioAmp Diagnostics is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
What does BioAmp Diagnostics do?
BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.
Who are the top competitors of BioAmp Diagnostics?
BioAmp Diagnostics's top competitors include Araceli Biosciences, Lodestone Biomedical and BioImage.
What products or services does BioAmp Diagnostics offer?
BioAmp Diagnostics offers DETECT Technology.
Who are BioAmp Diagnostics's investors?
BioAmp Diagnostics has 4 investors. Key investors include Illumina, National Science Foundation, America’s Seed Fund, and CITRIS Foundry.